From Chile’s Forests to Fields, Syngenta Brings Botanical-Based Biofungicide to the Americas

BASEL, Chile & DAVIS, Calif.–(BUSINESS WIRE)–Innovation often begins by observing nature and drawing inspiration from it, a wisdom deeply rooted in the ancient Mapuche culture of Chile. Known and used for centuries, the Mapuche have traditionally utilized the bark’s high saponin content of Quillaja saponaria for cleansing and medicinal purposes, and today this ever-green tree … [Read more…]

Materialise Reports Fourth Quarter and Full Year 2025 Results

Regulated information1 LEUVEN, Belgium–(BUSINESS WIRE)–$MTLS–Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 … [Read more…]

Compass Pathways Announces Pricing of $150 Million Public Offering

LONDON & NEW YORK–(BUSINESS WIRE)–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain … [Read more…]

Paubox Named Best Email Encryption Software in G2’s 2026 Best Software Awards

The HIPAA compliant email leader earns back-to-back recognition on the Best Healthcare Software Products list, with less than 1% of vendors making the cut SAN FRANCISCO–(BUSINESS WIRE)–#emailencryption–Paubox, the leading provider of HIPAA compliant email security, has been named the best email encryption software by G2 in its 2026 Best Healthcare Software Products Awards. It’s the … [Read more…]

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will report fourth quarter and year-end 2025 financial results on February 25, 2026. Mirum will also host a conference call to discuss the fourth quarter and year-end 2025 financial results and recent corporate progress. Conference call details: Wednesday, February 25, 2026 4:30 p.m. … [Read more…]

Newman University and Garden City Community College Expand the Future of Healthcare in Southwest Kansas with Diagnostic Medical Sonography Degree

With the new bachelor’s degree program, students can complete a Diagnostic Medical Sonography program for as little as $750 a year GARDEN CITY, Kan.–(BUSINESS WIRE)–Newman University and Garden City Community College have announced a new bachelor’s degree in Diagnostic Medical Sonography. The program will launch this fall and was publicly revealed today at the Garden … [Read more…]

Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit

The new product reinforces Meridian’s leadership in enzyme stabilization and enables simplified and decentralized Next-Generation-Sequencing sample preparation. CINCINNATI–(BUSINESS WIRE)–The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit. The kit is designed … [Read more…]

Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate virtually in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference. Dr. Brady’s conversation … [Read more…]

LEO Pharma Delivers 10% Revenue Growth in 2025 and More Than Doubles Adjusted EBITDA Margin

BALLERUP, Denmark–(BUSINESS WIRE)–In 2025, LEO Pharma delivered a third consecutive year of double‑digit revenue growth (CER), at the upper end of guidance, and achieved a significant improvement in profitability, returning to positive net profit and free cash flow. The portfolio was strengthened by the launch of Anzupgo® in 10 additional markets, including the U.S., as … [Read more…]

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

MARSEILLE, France–(BUSINESS WIRE)–#Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one meetings at the following conference: Leerink Partners Global Healthcare Conference 2026 Dates: March 8–11, … [Read more…]